Brief: Bioretec Expects FDA Approval For RemeOs Screws In April 2023
Oct 14 (Reuters) - Bioretec Oy BRETEC.HE :
* BIORETEC UPDATES ESTIMATE OF U.S. REGISTRATION OF REMEOS
SCREWS
AND EXPECTS APPROVAL IN APRIL 2023
* PREVIOUSLY AUTHORIZATION WAS EXPECTED TO BE RECEIVED IN H2
2022
* SHALL SUPPLEMENT AUTHORIZATION REQUEST IN ACCORDANCE WITH
DE
NOVO REGISTRATION PROCESS BY END OF 2022
Source text for Eikon: ID:nWkr3BW1Dd
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million